Hydroxychloroquine & Azithromycin Boosted Survival Of Ventilated COVID-19 Patients By 200%: New Study Confirms | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

Hydroxychloroquine & Azithromycin Boosted Survival Of Ventilated COVID-19 Patients By 200%: New Study Confirms

Authored by Tom Ozimek via The Epoch Times,

A new study has found that the use of weight-adjusted hydroxychloroquine (HCQ) and azithromycin (AZM) improved the survival of ventilated COVID-19 patients by nearly 200 percent.

The observational study, which hasn’t yet been peer-reviewed, was based on a re-analysis of 255 patients on invasive mechanical ventilation (IMV) during the first two months of the pandemic in the United States.

The researchers found that when the HCQ–AZM combination was given at lower dosages to treat ventilated COVID-19 patients, the risk of death was more than three times higher.

“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the authors of the study noted.

Webmaster's Commentary: 

Let me see; weren't those the medications which were ocassionally banned by various states, and university ridiculed, for use against Covid 19 in the US?!?

One has to wonder; who wanted how many of our medically fragile to die from this illness, and why?!?
And how in the name of heaven did families surrender their rights to take care of their loved ones, "in the name of "standard orthodox medical care" to allow this to happen?!?

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA